PT-141 Peptide |Bremelanotide Melanocortin Peptide

PT-141 Peptide |Bremelanotide Melanocortin Peptide

Blog Article

PT-141 Peptide, also known as Bremelanotide, is a synthetic melanocortin-receptor agonist peptide that has been researched for its effects on sexual desire and arousal pathways. It acts on melanocortin receptors in the nervous system rather more info than functioning as a testosterone or hormone replacement product.

Bremelanotide is the active ingredient in an FDA-approved prescription medicine for a specific sexual desire disorder in premenopausal women. However, research-grade PT-141 products sold separately may not have the same formulation, approval, quality controls, or approved indications.

Product Highlights

Contains PT-141 Peptide

Synthetic melanocortin peptide

Studied in relation to sexual desire and arousal pathways

Acts through melanocortin receptors

Suitable for research-focused peptide collections where permitted

Potential Benefits:

Sexual desire: Bremelanotide is FDA-approved in the U.S. for acquired, generalized HSDD in certain premenopausal women.

Sexual arousal: It acts on melanocortin receptors involved in sexual-response pathways.

Libido research: PT-141 has been studied for effects on sexual motivation and desire in both male and female populations.

Non-hormonal mechanism: Unlike testosterone products, PT-141 works through melanocortin-receptor signaling rather than replacing sex hormones.

Research Information

PT-141 has been investigated for its influence on melanocortin signaling and sexual-response pathways. Research has also explored its potential effects in both male and female sexual-function contexts.

Report this page